Fabrizio Vernieri
Biography
Associate Professor of Neurology, he is present at theUniversità Campus Bio-Medico di Roma since 2002. He is Head of the Headache and Neurosonology Simple Operating Unit, within the Complex Neurology Unit of the Campus Bio-Medico Polyclinic Foundation. He is professor and deputy director of the School of Specialization of Neurology. He carries out research activities in various fields of neuroscience, in particular headaches, cerebrovascular diseases and dementias, with the production of 195 papers in journals with impact factor.
Curriculum
Positions
From 1 November 2005 to 31 October 2017 University Researcher in Neurology MED-26 at theUniversità Campus Bio-Medico di Roma.
From 1 March 2011 to 30 June 2012 he was Head of the Complex Operative Unit of Neurology at the Campus Bio-Medico University Hospital in Rome.
From 1 July 2012 to 28 February 2016 he was Head of the Simple Dementia Operative Unit of the Campus Bio-Medico University Hospital in Rome.
From 1 March 2016 to today he is Head of the Simple Headache and Neurosonology Operating Unit of the Campus Bio-Medico University Hospital Foundation in Rome.
From 1 November 2017 Associate Professor of Neurology MED/26.
He obtained the eligibility for the position of Full Professor MED/26 on 28/3/2017.
Teaching activity
From 2002-03 to 2010-11 and then from 2013 to today: Professor of Neurology, within the Integrated Course of Neuropsychiatric Clinic, for the Medicine and Surgery degree course of theUniversità Campus Bio-Medico di Roma.
AA 2011-12: Teacher Coordinator of the Integrated Course in Clinical Neuropsychiatry, for the Degree course in Medicine and SurgeryUniversità Campus Bio-Medico di Roma.
From the academic year 2002-03 to today: Professor of Neurology and vice-director of the School of Specialization in Neurology ofUniversità Campus Bio-Medico di Roma.
From the academic year 2005-06 to today: Professor of Neurology in various specialization schools ofUniversità Campus Bio-Medico di Roma.
From AY 2006-07 to 2018-19: Professor of Neurology in the Integrated Course of Nursing for Disabilities, for the Nursing degree course of theUniversità Campus Bio-Medico di Roma.
From AY 2006-07 to AY 2009-10: Coordinating professor of Neurology in the integrated course of Neurology and Nutrition Psychopathology, for the Dietetics degree course of theUniversità Campus Bio-Medico di Roma.
From the AY 2019-20: Coordinator teacher of the integrated course in Neuropsychiatric Sciences of the degree course in Physiotherapy of theUniversità Campus Bio-Medico di Roma.
Member of the teaching body and tutor of the "CLINICAL NEUROSCIENCE" doctorate ofUniversità Campus Bio-Medico di ROMA.
Associate Editor of the Journal of Alzheimer's Disease (2014)
Associate Editor of Frontiers in Neurology, Headache and Neurogenic Pain Section (since 2020)
PUBLICATIONS
1: Altamura C, Ornello R, Ahmed F... and Vernieri F. OnabotulinumtoxinA in elderly patients with chronic migration: insights from a real-life European multicenter study. J Neurol. 2023 Feb;270(2):986-994.
2: Vernieri F, Brunelli N, Marcosano M, ...and Altamura C, Barbanti P; GARLIT Study Group. Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study. Eur J Neurol. 2023 Jan;30(1):224-234.
3: Barbanti P, Egeo G, Aurilia C, Altamura C, ... and Vernieri F; Italian Migraine Registry study group. Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients. J Headache Pain. 2022 Nov 1;23(1):138.
4: Altamura C, Brunelli N, Marcosano M, ... and Vernieri F; GARLIT Study Group. Conversion from chronic to episodic migration in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience. J Neurol. 2022 Nov;269(11):5848-5857.
5: Fofi L, Altamura C, Fiorentini G, Brunelli N, Marcosano M, Barbanti P, Vernieri F. Improving distress perception and mutuality in migraine caregivers after 6 months of galcanezumab treatment. Headache. 2022 Oct;62(9):1143-1147.
6: Lattanzi S, Trinka E, Altamura C, Del Giovane C, Silvestrini M, Brigo F, Vernieri F. Atogepant for the Prevention of Episodic Migraine in Adults: A Systematic Review and Meta-Analysis of Efficacy and Safety. Neurol Ther. 2022
Sep;11(3):1235-1252.
7: Altamura C, Brunelli N, Marcosano M, Fofi L, Vernieri F. Gepants - a long way to cure: a narrative review. Neurol Sci. 2022 Sep;43(9):5697-5708.
8: Brunelli N, Altamura C, Mallio CA, Lo Vullo G, Marcosano M, Bach-Pages M, Beomonte Zobel B, Quattrocchi CC, Vernieri F. Cerebral Hemodynamics, Right-to-Left Shunt and White Matter Hyperintensities in Patients with Migraine with Aura, Young Stroke Patients and Controls. Int J Environ Res Public Health. 2022 Jul 14;19(14):8575.
9: Barbanti P, Egeo G, Aurilia C, d'Onofrio F, Albanese M, Cetta I, Di Fiore P, Zucco M, Filippi M, Bono F, Altamura C, Proietti S, Bonassi S, Vernieri F; FRIEND-Study Group. Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study). J Headache Pain. 2022 Apr 9;23(1):46.
10: Vernieri F, Altamura C, Brunelli N, ...; GARLIT Study Group. Rapid response to galcanezumab and predictive factors in chronic migraine patients: A 3-observational, longitudinal, cohort, multicenter, Italian real-life study. Eur J Neurol. 2022 Apr;29(4):1198-1208.
11: Altamura C, Cevoli S, Brunelli N, Aurilia C, Fofi L, Egeo G, Barbanti P, Vernieri F; GARLIT Study Group collaborators. When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway? J Neurol. 2022 Feb;269(2):1032-1034.
12: Altamura C, Cascio Rizzo A, Viticchi G, Maggio P, Costa CM, Brunelli N, Giussani G, Paolucci M, Fiacco F, Di Lazzaro V, Agostoni EC, Silvestrini M, Vernieri F. Shorter visual aura characterizes young and middle-aged stroke
patients with migraine with aura. J Neurol. 2022 Feb;269(2):897-906.
13: Brunelli N, Altamura C, Costa CM, Altavilla R, Palazzo P, Maggio P, Marcosano M, Vernieri F. Carotid Artery Plaque Progression: Proposal of a New Predictive Score and Role of Carotid Intima-Media Thickness. Int J Environ Res Public Health. 2022 Jan 11;19(2):758 .
14: Vernieri F, Brunelli N, Messina R, Costa CM, Colombo B, Torelli P, Quintana S, Cevoli S, Favoni V, d'Onofrio F, Egeo G, Rao R, Filippi M, Barbanti P, Altamura C. Discontinuing Monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study. J Headache Pain. 2021 Dec 18;22(1):154.
